Literature DB >> 8189051

Peptide-induced conformational changes in class I molecules. Direct detection by flow cytometry.

E M Rohren1, D J McCormick, L R Pease.   

Abstract

Activation of a T cell in response to peptide bound to class I MHC occurs by the sum of interactions across the area of contact between the TCR, the peptide, and class I MHC. It has been observed recently that substitution of the peptide residue at a position that is not accessible from the exterior of the class I molecule modulates T cell responses, raising the possibility that there may be indirect structural effects in the peptide-class I complex as a consequence of peptide binding. This report describes the use of mAbs to probe the conformation of the alpha 1 and alpha 2 domains of the mouse class I molecule Kb when bound to ovalbumin peptide and a panel of 19 peptide analogues that differ at position 2 (P2). By crystallographic data, side chains of this position are buried in the Ag binding cleft and have no direct access to the TCR. Substitution of position 2 results in a measurable change in conformation of the class I molecule, a change that correlates with the ability to stimulate T cells. This leads to a model that T cell activation by the peptide-class I complex may occur in three ways: 1) direct interaction of the TCR with the class I heavy chain, 2) direct interaction of the TCR with solvent-accessible peptide side chains, and 3) indirect interaction of peptide with TCR mediated via conformational perturbations in the class I complex.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189051

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.

Authors:  Judith Racape; Francine Connan; Johan Hoebeke; Jeannine Choppin; Jean-Gérard Guillet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

2.  Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides.

Authors:  A V Chervonsky; R M Medzhitov; L K Denzin; A K Barlow; A Y Rudensky; C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

3.  On the calculation of binding free energies using continuum methods: application to MHC class I protein-peptide interactions.

Authors:  N Froloff; A Windemuth; B Honig
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

Review 4.  Conformational changes induced in the MHC class I molecule by peptide and beta 2-microglobulin.

Authors:  J C Solheim; J R Cook; T H Hansen
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

5.  Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.

Authors:  D H Fremont; E A Stura; M Matsumura; P A Peterson; I A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity.

Authors:  Natalie A Bowerman; Terence S Crofts; Lukasz Chlewicki; Priscilla Do; Brian M Baker; K Christopher Garcia; David M Kranz
Journal:  Mol Immunol       Date:  2009-09       Impact factor: 4.407

7.  MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains.

Authors:  W K Suh; E K Mitchell; Y Yang; P A Peterson; G L Waneck; D B Williams
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

8.  Different strategies adopted by K(b) and L(d) to generate T cell specificity directed against their respective bound peptides.

Authors:  Natalie A Bowerman; Leremy A Colf; K Christopher Garcia; David M Kranz
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

9.  A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences.

Authors:  F Huang; E Hermann; J Wang; X K Cheng; W C Tsai; J Wen; J G Kuipers; H Kellner; B Ackermann; G Roth; K M Williams; D K Yu; R B Raybourne
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.